$INSM
INSMED Inc

2023 Q4 Form 10-Q Financial Statement

#000110450623000025 Filed on October 26, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $83.69M $79.07M
YoY Change 41.13% 16.75%
Cost Of Revenue $18.44M $16.71M
YoY Change 41.12% 24.01%
Gross Profit $65.25M $62.37M
YoY Change 41.14% 14.94%
Gross Profit Margin 77.96% 78.87%
Selling, General & Admin $89.53M $90.63M
YoY Change 21.84% 19.91%
% of Gross Profit 137.21% 145.32%
Research & Development $137.0M $109.1M
YoY Change 9.83% 9.29%
% of Gross Profit 210.01% 175.01%
Depreciation & Amortization $3.411M $3.430M
YoY Change -4.21% 32.18%
% of Gross Profit 5.23% 5.5%
Operating Expenses $227.8M $109.1M
YoY Change 14.19% 9.29%
Operating Profit -$162.6M -$147.7M
YoY Change 6.07% 15.64%
Interest Expense -$10.93M $20.29M
YoY Change 34.5% 505.07%
% of Operating Profit
Other Income/Expense, Net $4.140M $285.0K
YoY Change -1145.45% -118.82%
Pretax Income -$185.1M -$158.4M
YoY Change 15.67% 21.12%
Income Tax $998.0K $500.0K
% Of Pretax Income
Net Earnings -$186.1M -$158.9M
YoY Change 16.2% 21.19%
Net Earnings / Revenue -222.31% -201.0%
Basic Earnings Per Share -$1.11
Diluted Earnings Per Share -$1.28 -$1.11
COMMON SHARES
Basic Shares Outstanding 143.1M shares 143.8M shares
Diluted Shares Outstanding 142.9M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $780.4M $785.9M
YoY Change -32.03% 53.11%
Cash & Equivalents $482.4M $487.1M
Short-Term Investments $298.1M $298.8M
Other Short-Term Assets $24.18M $27.10M
YoY Change -5.06% 7.57%
Inventory $83.25M $77.92M
Prepaid Expenses
Receivables $41.19M $35.58M
Other Receivables $0.00 $0.00
Total Short-Term Assets $929.1M $926.6M
YoY Change -27.04% 46.57%
LONG-TERM ASSETS
Property, Plant & Equipment $65.38M $64.63M
YoY Change 15.74% 20.39%
Goodwill $136.1M $136.1M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $96.57M $92.50M
YoY Change 26.9% 45.19%
Total Long-Term Assets $400.8M $398.3M
YoY Change 4.63% 9.83%
TOTAL ASSETS
Total Short-Term Assets $929.1M $926.6M
Total Long-Term Assets $400.8M $398.3M
Total Assets $1.330B $1.325B
YoY Change -19.72% 33.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $65.39M $65.38M
YoY Change 29.59% 464.76%
Accrued Expenses $154.3M $125.7M
YoY Change 13.09% -0.03%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $2.610M $2.500M
YoY Change 114.46% 641.84%
Total Short-Term Liabilities $225.6M $196.7M
YoY Change 18.6% 42.91%
LONG-TERM LIABILITIES
Long-Term Debt $1.155B $1.148B
YoY Change 2.67% 46.22%
Other Long-Term Liabilities $3.145M $5.918M
YoY Change -66.5% -47.81%
Total Long-Term Liabilities $1.158B $1.153B
YoY Change 2.1% 44.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $225.6M $196.7M
Total Long-Term Liabilities $1.158B $1.153B
Total Liabilities $1.662B $1.614B
YoY Change 5.95% 57.52%
SHAREHOLDERS EQUITY
Retained Earnings -$3.446B -$3.260B
YoY Change 27.8% 28.53%
Common Stock $1.480M $1.430M
YoY Change 9.06% 17.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$331.9M -$289.4M
YoY Change
Total Liabilities & Shareholders Equity $1.330B $1.325B
YoY Change -19.72% 33.18%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$186.1M -$158.9M
YoY Change 16.2% 21.19%
Depreciation, Depletion And Amortization $3.411M $3.430M
YoY Change -4.21% 32.18%
Cash From Operating Activities -$130.8M -$136.3M
YoY Change 26.82% 51.77%
INVESTING ACTIVITIES
Capital Expenditures $2.148M $2.860M
YoY Change -54.21% -591.41%
Acquisitions
YoY Change
Other Investing Activities $3.954M $10.00M
YoY Change -84.18% -80.0%
Cash From Investing Activities $1.806M $7.140M
YoY Change -91.11% -85.55%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 123.3M 1.250M
YoY Change -83.42% -96.63%
NET CHANGE
Cash From Operating Activities -130.8M -136.3M
Cash From Investing Activities 1.806M 7.140M
Cash From Financing Activities 123.3M 1.250M
Net Change In Cash -5.752M -127.9M
YoY Change -100.87% 3784.03%
FREE CASH FLOW
Cash From Operating Activities -$130.8M -$136.3M
Capital Expenditures $2.148M $2.860M
Free Cash Flow -$133.0M -$139.2M
YoY Change 23.3% 55.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate202006Member
us-gaap Interest Expense
InterestExpense
10001000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1255000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
614000 usd
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-1099000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-131602000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-566340000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-323765000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
44241000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-131145000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-457000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4069000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-29959000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19993000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-289357000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
410468000 usd
us-gaap Net Income Loss
NetIncomeLoss
-321411000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2354000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
17329000 usd
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2023#AccountingStandardsUpdate202006Member
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
143049197 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
143049197 shares
CY2023Q3 us-gaap Interest Expense
InterestExpense
20288000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
3353000 usd
us-gaap Interest Expense
InterestExpense
60910000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.06
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
120789000 shares
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-158933000 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
33383000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
4296000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15654000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-155745000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-158933000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-827000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2258000 usd
CY2023Q3 insm Stock Issued During Period Value Deferred Payment For Business Acquisition
StockIssuedDuringPeriodValueDeferredPaymentForBusinessAcquisition
3897000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
33383000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
4000 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
4296000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
42736000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-29959000 usd
us-gaap Net Income Loss
NetIncomeLoss
-563506000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2834000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10681000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
38014000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
5000 usd
insm Stock Issued During Period Value Deferred Payment For Business Acquisition
StockIssuedDuringPeriodValueDeferredPaymentForBusinessAcquisition
3897000 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
81640000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
54795000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-289357000 usd
us-gaap Net Income Loss
NetIncomeLoss
-563506000 usd
us-gaap Net Income Loss
NetIncomeLoss
-321411000 usd
us-gaap Depreciation
Depreciation
4052000 usd
us-gaap Depreciation
Depreciation
3095000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3789000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3789000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
54795000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
42736000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5568000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2465000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
17202000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
0 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
14016000 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
0 usd
insm Accretion Of Debt Discount Marketable Securities
AccretionOfDebtDiscountMarketableSecurities
6291000 usd
insm Accretion Of Debt Discount Marketable Securities
AccretionOfDebtDiscountMarketableSecurities
0 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
2034000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1846000 usd
insm Noncash Operating Lease Expense
NoncashOperatingLeaseExpense
8423000 usd
insm Noncash Operating Lease Expense
NoncashOperatingLeaseExpense
11440000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
12997000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-19002000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1650000 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
7428000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5440000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9179000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-624000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1196000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1806000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
16905000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
13023000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-6554000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
15137000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-5626000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-21352000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-405428000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-297290000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11135000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5187000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
292689000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
99706000 usd
insm Proceeds From Cash Acquired In Asset Acquisition
ProceedsFromCashAcquiredInAssetAcquisition
3417000 usd
insm Proceeds From Cash Acquired In Asset Acquisition
ProceedsFromCashAcquiredInAssetAcquisition
0 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
75000000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
50000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-54893000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
2383000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
830000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1218000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45176000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49886000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1264000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
148000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-586923000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-302149000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
487113000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
414633000 usd
us-gaap Interest Paid Net
InterestPaidNet
27461000 usd
us-gaap Interest Paid Net
InterestPaidNet
7442000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1880000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1626000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
487100000 usd
CY2023Q3 us-gaap Marketable Securities
MarketableSecurities
298800000 usd
us-gaap Net Income Loss
NetIncomeLoss
-563500000 usd
us-gaap Use Of Estimates
UseOfEstimates
<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The Company bases its estimates and judgments on historical experience and on various other assumptions. The amounts of assets and liabilities reported in the Company's balance sheets and the amounts of revenues and expenses reported for each period presented are affected by estimates and assumptions, which are used for, but not limited to, the accounting for revenue allowances, stock-based compensation, income taxes, loss contingencies, acquisition related intangibles including in process research and development (IPR&amp;D) and goodwill, fair value of contingent consideration, and accounting for research and development costs. Actual results could differ from those estimates.</span>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company places its cash equivalents with high credit-quality financial institutions and may invest its short-term investments in US treasury securities, mutual funds and government agency bonds. The Company has established guidelines relative to credit ratings and maturities that seek to maintain safety and liquidity.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to risks associated with extending credit to customers related to the sale of products. The Company does not require collateral to secure amounts due from its customers. The Company uses an expected loss methodology to calculate allowances for trade receivables. The Company's measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The Company does not currently have a material allowance for uncollectible trade receivables. The following table presents the percentage of gross product revenue represented by the Company's three largest customers as of the nine months ended September 30, 2023 and their respective percentages for the nine months ended September 30, 2022.</span></div><div style="margin-bottom:8pt;margin-top:8pt;padding-left:36pt;padding-right:36pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.116%"><tr><td style="width:1.0%"></td><td style="width:33.913%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.934%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.717%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.936%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer C</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on third-party manufacturers and suppliers for manufacturing and supply of its products. The inability of the suppliers or manufacturers to fulfill supply requirements of the Company could materially impact future operating results. A change in the relationship with the suppliers or manufacturers, or an adverse change in their business, could materially impact future operating results.</span></div>
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4970000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
565000 usd
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 reportingunit
CY2022 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 reportingunit
us-gaap Net Income Loss
NetIncomeLoss
-321411000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119780000 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119780000 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.68
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.68
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
26278000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
27245000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
31891000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
22460000 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
19754000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
20217000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
77923000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
69922000 usd
CY2023Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P12Y
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5100000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
298800000 usd
us-gaap Available For Sale Debt Securities Gross Unrealized Gain
AvailableForSaleDebtSecuritiesGrossUnrealizedGain
100000 usd
CY2023Q3 insm Business Combination Deferred Liability
BusinessCombinationDeferredLiability
4700000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
79072000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
67730000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
221515000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
186058000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5100000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5100000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
5100000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5100000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
9287000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
68756000 usd
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3789000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
64967000 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
73809000 usd
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
0 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3789000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
70020000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
136100000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
136100000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
107764000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
95936000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
43134000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
39445000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
64630000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
56491000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
65377000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
50461000 usd
CY2023Q3 insm Accrued Clinical Trial Expenses
AccruedClinicalTrialExpenses
21183000 usd
CY2022Q4 insm Accrued Clinical Trial Expenses
AccruedClinicalTrialExpenses
36456000 usd
CY2023Q3 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
19239000 usd
CY2022Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
14403000 usd
CY2023Q3 insm Accrued Technical Operation Expenses
AccruedTechnicalOperationExpenses
4252000 usd
CY2022Q4 insm Accrued Technical Operation Expenses
AccruedTechnicalOperationExpenses
3345000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
33870000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
32040000 usd
CY2023Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
5979000 usd
CY2022Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
4710000 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
2262000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
6340000 usd
CY2023Q3 insm Revenue Interest Payments Payable
RevenueInterestPaymentsPayable
3163000 usd
CY2022Q4 insm Revenue Interest Payments Payable
RevenueInterestPaymentsPayable
2149000 usd
CY2023Q3 insm Accrued Sales Allowancesand Related Costs
AccruedSalesAllowancesandRelatedCosts
9464000 usd
CY2022Q4 insm Accrued Sales Allowancesand Related Costs
AccruedSalesAllowancesandRelatedCosts
6974000 usd
CY2023Q3 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
15072000 usd
CY2022Q4 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
12943000 usd
CY2023Q3 insm Business Combination Deferred Payments Current
BusinessCombinationDeferredPaymentsCurrent
5700000 usd
CY2022Q4 insm Business Combination Deferred Payments Current
BusinessCombinationDeferredPaymentsCurrent
10700000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2222000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1596000 usd
CY2023Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
187783000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
182117000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
8100000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
4900000 usd
insm Lessee Operating Lease Lease Not Yet Commenced Amount
LesseeOperatingLeaseLeaseNotYetCommencedAmount
47000000 usd
CY2022 insm Lessee Operating Lease Lease Not Yet Commenced Amount
LesseeOperatingLeaseLeaseNotYetCommencedAmount
40700000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
17200000 usd
CY2023Q3 insm Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
575000000 usd
CY2023Q3 us-gaap Accrued Royalties Current And Noncurrent
AccruedRoyaltiesCurrentAndNoncurrent
153430000 usd
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
143049197 shares
CY2021Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
25.00
CY2021Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
17500000 usd
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
200000000 shares
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
insm Share Based Compensation Arrangement By Share Based Payment Award Inducement Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardInducementOptionsGrantsInPeriodGross
2135330 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1600000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1300000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 usd
CY2023Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
2600000 usd
CY2022Q3 us-gaap Operating Lease Expense
OperatingLeaseExpense
2000000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
6900000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
5900000 usd
CY2023Q2 us-gaap Share Price
SharePrice
21.10
CY2021Q2 insm Business Acquisition Consecutive Trading Day Period
BusinessAcquisitionConsecutiveTradingDayPeriod
45 days
CY2023Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
true
CY2023Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
true

Files In Submission

Name View Source Status
0001104506-23-000025-index-headers.html Edgar Link pending
0001104506-23-000025-index.html Edgar Link pending
0001104506-23-000025.txt Edgar Link pending
0001104506-23-000025-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
insm-20230930.htm Edgar Link pending
insm-20230930.xsd Edgar Link pending
insm-20230930ex311.htm Edgar Link pending
insm-20230930ex312.htm Edgar Link pending
insm-20230930ex321.htm Edgar Link pending
insm-20230930ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
insm-20230930_cal.xml Edgar Link unprocessable
insm-20230930_def.xml Edgar Link unprocessable
insm-20230930_lab.xml Edgar Link unprocessable
insm-20230930_pre.xml Edgar Link unprocessable
insm-20230930_htm.xml Edgar Link completed
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable